Jason Throne, SVP, General Counsel at IDEAYA Biosciences, Inc. (IDYA), sold 16,468 shares at $22.16 ($366K) on 2021-07-06, disclosed to the SEC on 2021-07-08.
Open-market sale of $366k IDYA by SVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.16 | 2,031 | $45K | 12.3% |
| 2 | $22.16 | 6,468 | $143K | 39.2% |
| 3 | $22.16 | 6,468 | $143K | 39.2% |
| 4 | $22.68 | 359 | $8K | 2.2% |
| 5 | $22.68 | 1,142 | $26K | 7.1% |
| Total | $22.21 avg | 16,468 |
| $366K |
| 100% |
| Filing → |
| IDYA | SELL | 2023-09-14 | $30K | — | Filing → |
| IDYA | SELL | 2023-09-06 | $167K | — | Filing → |
| IDYA | SELL | 2023-08-11 | $125K | — | Filing → |